iotaMotion Announces New Patent for Robotic Cochlear Implantation
In an exciting development, iotaMotion, Inc., located in St. Paul, Minnesota, has announced the issuance of a significant US patent (No. 12,311,173) focused on robotic-assisted cochlear implantation technology. This innovative advancement solidifies iotaMotion's position as a leader in enhancing cochlear implant surgery beyond human capabilities.
A Significant Milestone
iotaMotion aims to revolutionize cochlear implant procedures with this patent, which introduces distinct concepts involving separate positioning and drive components. These components are designed to optimize the application of robotic positioning during surgeries. CEO Mike Lobinsky expressed that this patent marks a substantial achievement for iotaMotion, highlighting the expansion of their intellectual property portfolio and augmenting their technology roadmap.
The announcement follows recent NIH grants awarded for iotaMotion's foundational technology, the iotaSOFT® Insertion System. These grants are intended to evaluate innovative applications for assisting in the positioning of electrode arrays using advanced shape-changing polymers. Additionally, iotaMotion is developing a navigation-based cochlear implant aimed at refining the trajectory during implantation procedures.
Recognition of Industry Efforts
Costa Nikou, Chief Technology Officer at iotaMotion, expressed pride that their industry-leading efforts have been recognized through this patent. He noted that alongside financial-backed initiatives, this milestone underscores the critical role their technology plays in both clinical practice and research, shaping the future landscape of cochlear implantation.
Furthermore, iotaMotion is committed to further advances in the field through collaborations with both academic institutions and industrial partners. It is anticipated that future cochlear implants will integrate robotic assistance technologies, such as navigation and electrocochleography, enhancing surgical outcomes even further.
With a track record of hundreds of successful implantations using the iotaSOFT system across more than 25 surgical centers in the United States, iotaMotion is poised for continued commercial growth while diversifying its product offerings.
About iotaMotion
iotaMotion, Inc. stands at the forefront of transforming cochlear implant surgery. Headquartered in St. Paul, Missouri, the company's flagship product, the iotaSOFT® Insertion System, is innovated to insert electrode arrays slowly and steadily, protecting delicate cochlear structures. Currently available in the U.S. market, iotaMotion's technology is also undergoing clinical trials in various global regions.
For more information about iotaMotion and their groundbreaking work in cochlear implantation technology, visit
www.iotamotion.com or reach out to Wade Colburn, Vice President of Marketing and Clinical, at [email protected].